| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Non-alcoholic Fatty Liver Disease | 4 | 2022 | 67 | 1.940 |
Why?
|
| PQQ Cofactor | 3 | 2022 | 7 | 1.520 |
Why?
|
| Liver | 8 | 2024 | 423 | 1.520 |
Why?
|
| Space Flight | 3 | 2017 | 17 | 1.240 |
Why?
|
| Antioxidants | 2 | 2021 | 222 | 1.140 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2024 | 121 | 1.010 |
Why?
|
| Mass Spectrometry | 11 | 2016 | 188 | 1.000 |
Why?
|
| Fatty Liver | 3 | 2018 | 55 | 0.990 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2024 | 100 | 0.980 |
Why?
|
| Tryptophan | 1 | 2024 | 38 | 0.920 |
Why?
|
| Diet, Western | 1 | 2024 | 19 | 0.920 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2024 | 26 | 0.890 |
Why?
|
| Immunity, Innate | 1 | 2024 | 211 | 0.790 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 35 | 0.770 |
Why?
|
| Health | 1 | 2021 | 12 | 0.770 |
Why?
|
| Vitamins | 1 | 2021 | 22 | 0.770 |
Why?
|
| Disease | 1 | 2021 | 15 | 0.760 |
Why?
|
| Pelvic Pain | 2 | 2016 | 10 | 0.660 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 1405 | 0.630 |
Why?
|
| Pregnancy | 6 | 2024 | 1148 | 0.570 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 72 | 0.570 |
Why?
|
| Proteinuria | 2 | 2014 | 13 | 0.570 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 80 | 0.560 |
Why?
|
| Autophagy | 1 | 2017 | 70 | 0.550 |
Why?
|
| Animals | 15 | 2024 | 10063 | 0.550 |
Why?
|
| Mindfulness | 1 | 2016 | 8 | 0.540 |
Why?
|
| Proteins | 5 | 2014 | 245 | 0.540 |
Why?
|
| Obesity | 3 | 2018 | 651 | 0.520 |
Why?
|
| Military Personnel | 1 | 2016 | 45 | 0.520 |
Why?
|
| Pain Management | 1 | 2016 | 56 | 0.510 |
Why?
|
| Adaptation, Psychological | 1 | 2016 | 117 | 0.510 |
Why?
|
| Mice | 9 | 2024 | 4464 | 0.490 |
Why?
|
| Sirtuin 3 | 2 | 2011 | 18 | 0.450 |
Why?
|
| Diet, High-Fat | 3 | 2022 | 134 | 0.450 |
Why?
|
| Female | 11 | 2024 | 14625 | 0.420 |
Why?
|
| Proteomics | 7 | 2013 | 177 | 0.410 |
Why?
|
| Lipid Metabolism | 3 | 2022 | 121 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 1494 | 0.400 |
Why?
|
| Peptide Mapping | 3 | 2010 | 22 | 0.390 |
Why?
|
| Antigens, Plant | 2 | 2010 | 2 | 0.370 |
Why?
|
| Metabolomics | 4 | 2017 | 82 | 0.370 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 71 | 0.350 |
Why?
|
| Oxidative Stress | 3 | 2022 | 630 | 0.350 |
Why?
|
| Trigonella | 1 | 2010 | 2 | 0.350 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2007 | 71 | 0.340 |
Why?
|
| Energy Metabolism | 1 | 2011 | 184 | 0.330 |
Why?
|
| PPAR alpha | 2 | 2022 | 32 | 0.330 |
Why?
|
| Dietary Supplements | 2 | 2022 | 220 | 0.290 |
Why?
|
| Peptide Fragments | 2 | 2007 | 200 | 0.280 |
Why?
|
| Humans | 22 | 2022 | 27125 | 0.280 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 438 | 0.270 |
Why?
|
| Chromosomes, Human | 1 | 2006 | 31 | 0.260 |
Why?
|
| Diet | 2 | 2021 | 224 | 0.250 |
Why?
|
| Interleukin-10 | 1 | 2024 | 67 | 0.220 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2024 | 53 | 0.220 |
Why?
|
| Macrophages | 2 | 2024 | 280 | 0.220 |
Why?
|
| Microbiota | 1 | 2022 | 80 | 0.180 |
Why?
|
| Longevity | 1 | 2022 | 129 | 0.180 |
Why?
|
| Reproducibility of Results | 6 | 2014 | 751 | 0.180 |
Why?
|
| Male | 5 | 2024 | 13008 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2022 | 123 | 0.180 |
Why?
|
| Food Hypersensitivity | 2 | 2010 | 3 | 0.170 |
Why?
|
| Metabolome | 2 | 2017 | 66 | 0.170 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 455 | 0.160 |
Why?
|
| Child | 6 | 2022 | 2164 | 0.160 |
Why?
|
| Transcriptome | 2 | 2017 | 205 | 0.160 |
Why?
|
| Fibrosis | 1 | 2019 | 121 | 0.150 |
Why?
|
| Adult | 3 | 2022 | 7494 | 0.150 |
Why?
|
| Liver Transplantation | 1 | 2019 | 51 | 0.150 |
Why?
|
| Betaine | 1 | 2017 | 4 | 0.150 |
Why?
|
| Maternal Exposure | 1 | 2018 | 17 | 0.150 |
Why?
|
| RNA, Transfer | 1 | 2017 | 16 | 0.150 |
Why?
|
| Oxidation-Reduction | 2 | 2017 | 353 | 0.150 |
Why?
|
| Phenotype | 2 | 2018 | 665 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 46 | 0.140 |
Why?
|
| Adrenal Glands | 1 | 2017 | 21 | 0.140 |
Why?
|
| Cluster Analysis | 1 | 2017 | 119 | 0.140 |
Why?
|
| Glutathione | 1 | 2017 | 70 | 0.140 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 109 | 0.140 |
Why?
|
| Biopsy | 1 | 2018 | 201 | 0.140 |
Why?
|
| Angiotensin I | 2 | 1996 | 2 | 0.140 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 15 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 39 | 0.140 |
Why?
|
| Disease Progression | 1 | 2019 | 457 | 0.140 |
Why?
|
| Spleen | 1 | 2017 | 109 | 0.140 |
Why?
|
| PPAR gamma | 1 | 2016 | 29 | 0.140 |
Why?
|
| Ceramides | 1 | 2016 | 24 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 68 | 0.140 |
Why?
|
| Cellular Senescence | 1 | 2017 | 121 | 0.140 |
Why?
|
| Viral Proteins | 1 | 1997 | 62 | 0.130 |
Why?
|
| Phosphoproteins | 1 | 1997 | 116 | 0.130 |
Why?
|
| Hepatic Stellate Cells | 1 | 2016 | 14 | 0.130 |
Why?
|
| Lipid Droplets | 1 | 2016 | 7 | 0.130 |
Why?
|
| Systems Biology | 1 | 2016 | 21 | 0.130 |
Why?
|
| Focus Groups | 1 | 2016 | 89 | 0.130 |
Why?
|
| Annexin A2 | 1 | 2016 | 3 | 0.130 |
Why?
|
| Complement Factor H | 1 | 2016 | 14 | 0.130 |
Why?
|
| Peptides | 2 | 2004 | 280 | 0.130 |
Why?
|
| Psychometrics | 1 | 2016 | 117 | 0.130 |
Why?
|
| Cytokines | 2 | 2016 | 438 | 0.130 |
Why?
|
| Complement Activation | 1 | 2016 | 25 | 0.130 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 5 | 2010 | 38 | 0.130 |
Why?
|
| Interleukin-6 | 1 | 2016 | 190 | 0.120 |
Why?
|
| Chronic Pain | 1 | 2016 | 59 | 0.120 |
Why?
|
| Body Weight | 1 | 2016 | 247 | 0.120 |
Why?
|
| Chemical Precipitation | 1 | 2014 | 6 | 0.120 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2010 | 128 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2016 | 397 | 0.120 |
Why?
|
| Reference Standards | 1 | 2014 | 54 | 0.120 |
Why?
|
| Specimen Handling | 1 | 2014 | 30 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2010 | 113 | 0.120 |
Why?
|
| Inflammation | 1 | 2019 | 605 | 0.120 |
Why?
|
| Stress, Psychological | 1 | 2016 | 209 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 254 | 0.110 |
Why?
|
| Proteome | 2 | 2007 | 76 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2016 | 647 | 0.110 |
Why?
|
| Kallikreins | 1 | 2013 | 4 | 0.110 |
Why?
|
| Pancreatic Elastase | 1 | 1993 | 8 | 0.110 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 51 | 0.110 |
Why?
|
| Polysaccharides | 1 | 2013 | 61 | 0.100 |
Why?
|
| Biomarkers | 1 | 2016 | 736 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 927 | 0.100 |
Why?
|
| Myoglobin | 1 | 1993 | 32 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2013 | 119 | 0.100 |
Why?
|
| Amino Acid Sequence | 4 | 2010 | 674 | 0.100 |
Why?
|
| Chromatography, Liquid | 4 | 2016 | 75 | 0.090 |
Why?
|
| Cell Respiration | 1 | 2011 | 9 | 0.090 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2004 | 54 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 2010 | 1036 | 0.090 |
Why?
|
| Acetylation | 1 | 2011 | 36 | 0.090 |
Why?
|
| Insulin | 1 | 1993 | 313 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 509 | 0.090 |
Why?
|
| Allergens | 1 | 2010 | 10 | 0.090 |
Why?
|
| Serologic Tests | 1 | 2010 | 19 | 0.090 |
Why?
|
| Cross Reactions | 1 | 2010 | 71 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2010 | 191 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 141 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2008 | 1372 | 0.080 |
Why?
|
| Body Fluids | 1 | 2008 | 18 | 0.080 |
Why?
|
| Obstetric Labor, Premature | 1 | 2008 | 15 | 0.080 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 58 | 0.080 |
Why?
|
| Kidney | 1 | 2010 | 275 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2011 | 792 | 0.070 |
Why?
|
| Phosphorylation | 4 | 2008 | 566 | 0.070 |
Why?
|
| Vagina | 1 | 2008 | 42 | 0.070 |
Why?
|
| Mitochondria | 1 | 2011 | 333 | 0.070 |
Why?
|
| Lung | 2 | 2007 | 360 | 0.070 |
Why?
|
| Acrolein | 1 | 2007 | 1 | 0.070 |
Why?
|
| Energy Transfer | 1 | 2007 | 7 | 0.070 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2007 | 7 | 0.070 |
Why?
|
| Databases, Protein | 1 | 2007 | 22 | 0.070 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2007 | 13 | 0.070 |
Why?
|
| Blood Chemical Analysis | 1 | 2007 | 17 | 0.070 |
Why?
|
| Pulmonary Artery | 1 | 2007 | 68 | 0.070 |
Why?
|
| Amino Acids | 1 | 2007 | 81 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 280 | 0.060 |
Why?
|
| DNA | 1 | 2007 | 365 | 0.060 |
Why?
|
| Middle Aged | 1 | 2016 | 6901 | 0.060 |
Why?
|
| Apoptosis | 1 | 2008 | 738 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2008 | 468 | 0.060 |
Why?
|
| Hypertension | 1 | 2007 | 305 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 627 | 0.050 |
Why?
|
| Seroconversion | 1 | 2022 | 4 | 0.050 |
Why?
|
| Metagenome | 1 | 2022 | 50 | 0.050 |
Why?
|
| Metagenomics | 1 | 2022 | 49 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2016 | 506 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 83 | 0.040 |
Why?
|
| Infant | 4 | 2022 | 970 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2022 | 472 | 0.040 |
Why?
|
| Receptors, Corticotropin | 1 | 2017 | 2 | 0.040 |
Why?
|
| Immune System Diseases | 1 | 2017 | 4 | 0.040 |
Why?
|
| Catecholamines | 1 | 2017 | 18 | 0.040 |
Why?
|
| Buffers | 2 | 2010 | 24 | 0.040 |
Why?
|
| Corticosterone | 1 | 2017 | 33 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2017 | 16 | 0.040 |
Why?
|
| Chymotrypsin | 1 | 1997 | 4 | 0.030 |
Why?
|
| Caseins | 1 | 1997 | 2 | 0.030 |
Why?
|
| Leukocytes | 1 | 2017 | 69 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1997 | 36 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2017 | 79 | 0.030 |
Why?
|
| Models, Animal | 1 | 2017 | 128 | 0.030 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2016 | 28 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 31 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 111 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2016 | 87 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2016 | 68 | 0.030 |
Why?
|
| Otitis Media | 1 | 2016 | 35 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 394 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 279 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 73 | 0.030 |
Why?
|
| Rats | 2 | 2010 | 1544 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 145 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 324 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 285 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2008 | 264 | 0.030 |
Why?
|
| Cell Line | 2 | 2008 | 679 | 0.030 |
Why?
|
| Laboratories | 1 | 2013 | 18 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2016 | 851 | 0.030 |
Why?
|
| Glycosylation | 1 | 2013 | 69 | 0.030 |
Why?
|
| Angiotensinogen | 1 | 1993 | 2 | 0.030 |
Why?
|
| Whales | 1 | 1993 | 2 | 0.030 |
Why?
|
| K562 Cells | 2 | 2004 | 20 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1993 | 118 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 1997 | 474 | 0.030 |
Why?
|
| Lasers | 1 | 1993 | 67 | 0.030 |
Why?
|
| Swine | 1 | 1993 | 220 | 0.020 |
Why?
|
| Cattle | 1 | 1993 | 383 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 2036 | 0.020 |
Why?
|
| NAD | 1 | 2011 | 82 | 0.020 |
Why?
|
| Daucus carota | 1 | 2010 | 1 | 0.020 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2010 | 5 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2011 | 73 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 55 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 130 | 0.020 |
Why?
|
| Vegetables | 1 | 2010 | 27 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 48 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2010 | 149 | 0.020 |
Why?
|
| Plant Proteins | 1 | 2010 | 64 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 18 | 0.020 |
Why?
|
| Lymphoma | 1 | 2008 | 22 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 45 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 44 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2008 | 71 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2008 | 68 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2008 | 67 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2007 | 6 | 0.020 |
Why?
|
| Monocrotaline | 1 | 2007 | 4 | 0.020 |
Why?
|
| Gestational Age | 1 | 2008 | 141 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2007 | 13 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2008 | 121 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 26 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 38 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 154 | 0.020 |
Why?
|
| Arginine | 1 | 2007 | 39 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2007 | 37 | 0.020 |
Why?
|
| Aldehydes | 1 | 2007 | 55 | 0.020 |
Why?
|
| Smoke | 1 | 2007 | 33 | 0.020 |
Why?
|
| Cysteine | 1 | 2007 | 68 | 0.020 |
Why?
|
| Tobacco | 1 | 2007 | 86 | 0.020 |
Why?
|
| Hypoxia | 1 | 2007 | 85 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 317 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 122 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2007 | 265 | 0.020 |
Why?
|
| Tuberculosis | 3 | 1952 | 23 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 538 | 0.020 |
Why?
|
| Poliomyelitis | 3 | 1954 | 6 | 0.020 |
Why?
|
| Protein Binding | 1 | 2007 | 635 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2007 | 975 | 0.010 |
Why?
|
| Alkylation | 1 | 2004 | 17 | 0.010 |
Why?
|
| Trypsin | 1 | 2004 | 24 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 1572 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 2004 | 14 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2004 | 67 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 262 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 959 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 246 | 0.010 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2000 | 2 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2000 | 7 | 0.010 |
Why?
|
| Butadienes | 1 | 2000 | 14 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2000 | 31 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 26 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2000 | 20 | 0.010 |
Why?
|
| Nitriles | 1 | 2000 | 32 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2000 | 95 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 1267 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 312 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 247 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 538 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 821 | 0.010 |
Why?
|
| Chlortetracycline | 2 | 1953 | 2 | 0.010 |
Why?
|
| Epidemics | 2 | 1952 | 4 | 0.010 |
Why?
|
| Seizures | 1 | 1955 | 46 | 0.010 |
Why?
|
| Rabies Vaccines | 1 | 1954 | 1 | 0.010 |
Why?
|
| Paralysis | 1 | 1954 | 9 | 0.010 |
Why?
|
| Vaccines | 1 | 1954 | 29 | 0.010 |
Why?
|
| Appetite | 1 | 1953 | 19 | 0.010 |
Why?
|
| Feeding and Eating Disorders | 1 | 1953 | 12 | 0.010 |
Why?
|
| Dermatomycoses | 1 | 1953 | 3 | 0.010 |
Why?
|
| Vaccination | 1 | 1954 | 171 | 0.010 |
Why?
|
| Mycoses | 1 | 1953 | 8 | 0.010 |
Why?
|
| Rheumatic Fever | 1 | 1953 | 6 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1953 | 28 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 1952 | 32 | 0.010 |
Why?
|
| Nicotinic Acids | 1 | 1952 | 2 | 0.010 |
Why?
|
| Isoniazid | 1 | 1952 | 2 | 0.010 |
Why?
|
| Niacin | 1 | 1952 | 2 | 0.010 |
Why?
|
| Antibiotics, Antitubercular | 1 | 1951 | 4 | 0.010 |
Why?
|
| Dermatologic Agents | 1 | 1951 | 3 | 0.010 |
Why?
|
| Quartz | 1 | 1950 | 4 | 0.010 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 1950 | 6 | 0.010 |
Why?
|
| Tuberculosis, Meningeal | 1 | 1950 | 3 | 0.010 |
Why?
|
| Streptomycin | 1 | 1950 | 14 | 0.010 |
Why?
|
| Household Articles | 1 | 1950 | 6 | 0.010 |
Why?
|
| Meningitis | 1 | 1950 | 11 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1950 | 41 | 0.010 |
Why?
|
| Pediatrics | 1 | 1951 | 87 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 1951 | 497 | 0.000 |
Why?
|